Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box–Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and In Vivo Assessment
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2024-03-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.3c10506 |
ISSN: | 2470-1343 |
---|